Brown Advisory Inc. lessened its holdings in shares of DENTSPLY SIRONA Inc (NASDAQ:XRAY) by 15.4% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 64,484 shares of the medical instruments supplier’s stock after selling 11,741 shares during the period. Brown Advisory Inc.’s holdings in DENTSPLY SIRONA were worth $2,434,000 as of its most recent SEC filing.
Other hedge funds have also made changes to their positions in the company. Cornerstone Wealth Management LLC bought a new stake in shares of DENTSPLY SIRONA during the second quarter worth about $202,000. Piedmont Investment Advisors LLC bought a new stake in shares of DENTSPLY SIRONA during the second quarter worth about $117,000. Sumitomo Mitsui Trust Holdings Inc. increased its position in shares of DENTSPLY SIRONA by 5.7% during the second quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 709,140 shares of the medical instruments supplier’s stock worth $31,039,000 after acquiring an additional 38,183 shares in the last quarter. Comerica Bank increased its position in shares of DENTSPLY SIRONA by 2.3% during the second quarter. Comerica Bank now owns 61,333 shares of the medical instruments supplier’s stock worth $2,803,000 after acquiring an additional 1,400 shares in the last quarter. Finally, Wells Fargo & Company MN increased its position in shares of DENTSPLY SIRONA by 15.4% during the second quarter. Wells Fargo & Company MN now owns 1,021,008 shares of the medical instruments supplier’s stock worth $44,691,000 after acquiring an additional 136,189 shares in the last quarter. 96.21% of the stock is currently owned by hedge funds and other institutional investors.
DENTSPLY SIRONA stock opened at $36.31 on Friday. DENTSPLY SIRONA Inc has a fifty-two week low of $33.93 and a fifty-two week high of $68.47. The stock has a market cap of $8.19 billion, a P/E ratio of 13.65, a PEG ratio of 2.24 and a beta of 1.18. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.14 and a current ratio of 1.76.
DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings results on Thursday, November 8th. The medical instruments supplier reported $0.38 earnings per share for the quarter, missing the consensus estimate of $0.46 by ($0.08). DENTSPLY SIRONA had a positive return on equity of 8.68% and a negative net margin of 41.97%. The firm had revenue of $928.40 million for the quarter, compared to analysts’ expectations of $951.58 million. During the same quarter last year, the firm posted $0.70 earnings per share. The firm’s revenue for the quarter was down 8.0% compared to the same quarter last year. As a group, research analysts anticipate that DENTSPLY SIRONA Inc will post 1.97 earnings per share for the current year.
XRAY has been the subject of several recent research reports. Goldman Sachs Group raised shares of DENTSPLY SIRONA from a “sell” rating to a “buy” rating and set a $44.00 target price for the company in a research report on Friday, October 19th. TheStreet downgraded shares of DENTSPLY SIRONA from a “c-” rating to a “d+” rating in a research report on Tuesday, August 14th. HC Wainwright set a $40.00 target price on shares of DENTSPLY SIRONA and gave the stock a “hold” rating in a research report on Friday, August 31st. BidaskClub raised shares of DENTSPLY SIRONA from a “sell” rating to a “hold” rating in a research report on Wednesday, November 21st. Finally, Zacks Investment Research reissued a “hold” rating on shares of DENTSPLY SIRONA in a research report on Saturday, November 17th. One analyst has rated the stock with a sell rating, ten have issued a hold rating and six have given a buy rating to the company. DENTSPLY SIRONA has an average rating of “Hold” and an average price target of $51.50.
In related news, insider Markus Boehringer sold 7,373 shares of the business’s stock in a transaction dated Monday, December 3rd. The shares were sold at an average price of $37.86, for a total transaction of $279,141.78. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 1.93% of the stock is currently owned by insiders.
COPYRIGHT VIOLATION NOTICE: This news story was published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this news story on another website, it was illegally copied and republished in violation of U.S. & international copyright & trademark laws. The original version of this news story can be read at https://www.dispatchtribunal.com/2018/12/08/dentsply-sirona-inc-xray-position-trimmed-by-brown-advisory-inc.html.
DENTSPLY SIRONA Company Profile
DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.
Recommended Story: Buyback For Investors Defined
Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc (NASDAQ:XRAY).
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.